litlas
Log inCreate account

Chris J. Packard

Active 1984–2026

118
Papers
35,969
Citations
86
h-index
116
i10-index

Citations

Citations per year for Chris J. Packard1964: 1 citations1984: 1 citations1985: 1 citations1986: 1 citations1987: 1 citations1988: 1 citations1989: 4 citations1990: 2 citations1991: 4 citations1992: 2 citations1993: 9 citations1994: 14 citations1995: 15 citations1996: 12 citations1997: 23 citations1998: 25 citations1999: 38 citations2000: 48 citations2001: 47 citations2002: 72 citations2003: 158 citations2004: 236 citations2005: 302 citations2006: 250 citations2007: 266 citations2008: 313 citations2009: 211 citations2010: 222 citations2011: 263 citations2012: 266 citations2013: 250 citations2014: 215 citations2015: 194 citations2016: 211 citations2017: 230 citations2018: 220 citations2019: 915 citations2020: 1,033 citations2021: 1,047 citations2022: 960 citations2023: 810 citations2024: 1,328 citations2025: 711 citations2026: 63 citations1965–1983: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,292 citing papers, 20.7% of this breakdownUnited Kingdom: 1,660 citing papers, 10.4% of this breakdownChina: 1,080 citing papers, 6.8% of this breakdownItaly: 772 citing papers, 4.9% of this breakdownNetherlands: 718 citing papers, 4.5% of this breakdownGermany: 681 citing papers, 4.3% of this breakdownCanada: 664 citing papers, 4.2% of this breakdownAustralia: 578 citing papers, 3.6% of this breakdownFrance: 457 citing papers, 2.9% of this breakdownSweden: 444 citing papers, 2.8% of this breakdownSpain: 413 citing papers, 2.6% of this breakdownDenmark: 347 citing papers, 2.2% of this breakdown
0%20.7%Other 30.1%

Institutions

Fields

  • Medicine75.2%
  • Biochemistry, Genetics and Molecular Biology14.5%
  • Immunology and Microbiology2.4%
  • Neuroscience1.9%
  • Nursing1.9%
  • Environmental Science0.6%
  • Other3.5%

Topics

  • Lipoproteins and Cardiovascular Health12.2%
  • Diabetes, Cardiovascular Risks, and Lipoproteins9.6%
  • Adipokines, Inflammation, and Metabolic Diseases3.5%
  • Cancer, Lipids, and Metabolism3.1%
  • Atherosclerosis and Cardiovascular Diseases2.6%
  • Liver Disease Diagnosis and Treatment2.5%
  • Other66.5%

Coauthors

All papers

Open in search
  1. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

    Authors: Brian A. Ference, Henry N. Ginsberg, Ian Graham, Kausik K. Ray, Chris J. Packard, Éric Bruckert, Robert A. Hegele, Ronald M. Krauss, Frederick J. Raal, Heribert Schunkert, Gerald F. Watts, Jan Borén, Sergio Fazio, Jay D. Horton, L. Masana, Stephen J. Nicholls, Børge G. Nordestgaard, Bart van de Sluis, Marja‐Riitta Taskinen, Lâle Tokgözoğlu, Ulf Landmesser, Ulrich Laufs, Olov Wiklund, Jane K. Stock, M. John Chapman, Alberico L. Catapano - European Heart Journal 2017 cited by 3,840

  2. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

    Authors: Jan Borén, M. John Chapman, Ronald M. Krauss, Chris J. Packard, Jacob Fog Bentzon, Christoph J. Binder, Mat J.A.P. Daemen, Linda L. Demer, Robert A. Hegele, Stephen J. Nicholls, Børge G. Nordestgaard, Gerald F. Watts, Éric Bruckert, Sergio Fazio, Brian A. Ference, Ian Graham, Jay D. Horton, Ulf Landmesser, Ulrich Laufs, L. Masana, Gerard Pasterkamp, Frederick J. Raal, Kausik K. Ray, Heribert Schunkert, Marja‐Riitta Taskinen, Bart van de Sluis, Olov Wiklund, Lâle Tokgözoğlu, Alberico L. Catapano, Henry N. Ginsberg - European Heart Journal 2020 cited by 1,527

  3. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society

    Authors: Henry N. Ginsberg, Chris J. Packard, M. John Chapman, Jan Borén, Carlos A. Aguilar‐Salinas, Maurizio Averna, Brian A. Ference, Daniel Gaudet, Robert A. Hegele, Sander Kersten, Gary F. Lewis, Alice H. Lichtenstein, Philippe Moulin, Børge G. Nordestgaard, Alan T. Remaley, Bart Staels, Erik S.G. Stroes, Marja‐Riitta Taskinen, Lâle Tokgözoğlu, Anne Tybjærg‐Hansen, Jane K. Stock, Alberico L. Catapano - European Heart Journal 2021 cited by 899

  4. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

    Authors: Naveed Sattar, David Preiss, Heather Murray, Paul Welsh, Brendan M. Buckley, Anton JM de Craen, Sreenivasa Rao Kondapally Seshasai, John J.V. McMurray, Dilys J. Freeman, J. Wouter Jukema, Peter W. Macfarlane, Chris J. Packard, David J. Stott, Rudi G. J. Westendorp, James Shepherd, Barry R. Davis, Sara Pressel, Roberto Marchioli, Rosa Maria Marfisi, Aldo P. Maggioni, Luigi Tavazzi, Gianni Tognoni, John Kjekshus, Terje R. Pedersen, Thomas J. Cook, Antonio M. Gotto, Michael Clearfield, John R. Downs, Haruo Nakamura, Yasuo Ohashi, Kyoichi Mizuno, Kausik K. Ray, Ian Ford - The Lancet 2010 cited by 2,447

  5. Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease

    Authors: Brian A. Ference, John J.P. Kastelein, Kausik K. Ray, Henry N. Ginsberg, M. John Chapman, Chris J. Packard, Ulrich Laufs, Clare Oliver‐Williams, Angela Wood, Adam S. Butterworth, Emanuele Di Angelantonio, John Danesh, Stephen J. Nicholls, Deepak L. Bhatt, Marc S. Sabatine, Alberico L. Catapano - JAMA 2019 cited by 711

  6. Association ofLPAVariants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies

    Authors: Stephen Burgess, Brian A. Ference, James R Staley, Daniel F. Freitag, Amy M. Mason, Sune F. Nielsen, Peter Willeit, Robin Young, Praveen Surendran, Savita Karthikeyan, Thomas R Bolton, James E. Peters, Pia R. Kamstrup, Anne Tybjærg‐Hansen, Marianne Benn, Anne Langsted, Peter Schnohr, Signe Vedel‐Krogh, Camilla J. Kobylecki, Ian Ford, Chris J. Packard, Stella Trompet, J. Wouter Jukema, Naveed Sattar, Emanuele Di Angelantonio, Danish Saleheen, Joanna M. M. Howson, Børge G. Nordestgaard, Adam S. Butterworth, John Danesh - JAMA Cardiology 2018 cited by 675

  7. Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia

    Authors: Jan Borén, Marja‐Riitta Taskinen, Elias Björnson, Chris J. Packard - Nature Reviews Cardiology 2022 cited by 308

  8. Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study

    Authors: Elias Björnson, Martin Adiels, Marja‐Riitta Taskinen, Stephen Burgess, Aidin Rawshani, Jan Borén, Chris J. Packard - European Heart Journal 2023 cited by 171

  9. Lipoprotein(a) Is Markedly More Atherogenic Than LDL

    Authors: Elias Björnson, Martin Adiels, Marja‐Riitta Taskinen, Stephen Burgess, M. John Chapman, Chris J. Packard, Jan Borén - Journal of the American College of Cardiology 2024 cited by 216

  10. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

    Authors: James Shepherd, Gerard J. Blauw, Michael Murphy, Edward Bollen, Brendan M. Buckley, Stuart M. Cobbe, Ian Ford, Allan Gaw, Michael E. Hyland, J. Wouter Jukema, Adriaan M. Kamper, Peter W. Macfarlane, A. Edo Meinders, John Norrie, Chris J. Packard, Ivan J. Perry, David J. Stott, Brian Sweeney, Gillian Twomey, Rudi GJ Westendorp - The Lancet 2002 cited by 3,396

  11. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

    Authors: Jane Armitage, Colin Baigent, Elizabeth H Barnes, D. J. Betteridge, Lisa Blackwell, Michael A. Blazing, Louise Bowman, Eugene Braunwald, Robert Byington, Christopher P. Cannon, Michael Clearfield, Helen M. Colhoun, Rory Collins, Björn Dahlöf, Kelly Davies, Barry R. Davis, James A. de Lemos, John R. Downs, Paul N. Durrington, Jonathan Emberson, Bengt Fellström, Marcus Flather, Ian Ford, Maria Grazia Franzosi, Jordan Fulcher, John A. Fuller, Curt D. Furberg, David Gordon, Shinya Goto, Antonio M. Gotto, Heather Halls, Charlie Harper, C. Hawkins, William G. Herrington, G. A. Hitman, Hallvard Holdaas, Lisa Holland, Alan G. Jardine, J. Wouter Jukema, John J.P. Kastelein, Sharon Kean, Anthony Keech, Adrienne Kirby, John Kjekshus, Genell L. Knatterud, Robert H. Knopp, Wolfgang Köenig, Michael J. Koren, Vera Krane, Martin Landray, John C. LaRosa, Eva Lonn, Peter W. Macfarlane, Stephen MacMahon, Aldo P. Maggioni, Roberto Marchioli, Ian C. Marschner, Borislava Mihaylova, Lemuel A. Moyé, Sabina A. Murphy, Haruo Nakamura, Andrew Neil, Connie B. Newman, Rachel O’Connell, Chris J. Packard, Sarah Parish, Terje Pedersen, Richard Peto, Marc A. Pfeffer, Neil Poulter, David Preiss, Christina Reith, Paul M. Ridker, Michele Robertson, Frank M. Sacks, Naveed Sattar, Roland E. Schmieder, Patrick W. Serruys, Peter Sever, John Shaw, Charles L. Shear, John Simes, Peter Sleight, Enti Spata, Luigi Tavazzi, Jonathan A. Tobert, Gianni Tognoni, Andrew Tonkin, Stella Trompet, George Varigos, Christoph Wanner, Hans Wedel, Harvey D. White, John Wikstrand, Lars Wilhelmsen, Kate Wilson, Robin Young, Salim Yusuf, Faı̈ez Zannad - The Lancet 2019 cited by 791

  12. Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials

    Authors: Christina Reith, Colin Baigent, Lisa Blackwell, Jonathan Emberson, Enti Spata, Kelly Davies, Heather Halls, Lisa Holland, Kate Wilson, Jane Armitage, Charlie Harper, David Preiss, Alistair Roddick, Anthony Keech, John Simes, Rory Collins, Elizabeth H Barnes, Jordan Fulcher, William G. Herrington, Adrienne Kirby, Borislava Mihaylova, Rachel O’Connell, Pierre Amarenco, Philip J. Barter, D. J. Betteridge, Michael A. Blazing, Jackie Bosch, Louise Bowman, Eugene Braunwald, Christopher P. Cannon, Michael Clearfield, Stuart M. Cobbe, Helen M. Colhoun, Björn Dahlöf, Barry R. Davis, James A. de Lemos, John R. Downs, Paul N. Durrington, Bengt Fellström, Ian Ford, Maria Grazia Franzosi, John A. Fuller, Curt D. Furberg, Robert J. Glynn, David Gordon, Antonio M. Gotto, Richard H. Grimm, Ajay Gupta, C. Hawkins, G. A. Hitman, Hallvard Holdaas, Alan G. Jardine, J. Wouter Jukema, John J.P. Kastelein, Sharon Kean, John Kjekshus, Genell L. Knatterud, Robert H. Knopp, Wolfgang Köenig, Michael J. Koren, Vera Krane, Martin Landray, John C. LaRosa, Roberto Latini, Eva Lonn, Donata Lucci, Jean MacFadyen, Peter W. Macfarlane, Stephen MacMahon, Aldo P. Maggioni, Roberto Marchioli, Ian C. Marschner, Lemuel A. Moyé, Sabina A. Murphy, Andrew Neil, Enrico Nicolis, Chris J. Packard, Sarah Parish, Terje R. Pedersen, Richard Peto, Marc A. Pfeffer, Neil R Poulter, Sara Pressel, Jeffrey L. Probstfield, Mahboob Rahman, Paul M. Ridker, Michele Robertson, Frank M. Sacks, Naveed Sattar, Roland E. Schmieder, Patrick W. Serruys, Peter Sever, John Shaw, James Shepherd, Lara M. Simpson, Peter Sleight, Luigi Tavazzi, Gianni Tognoni, Andrew Tonkin, Stella Trompet and 28 more - The Lancet 2022 cited by 246

  13. Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease

    Authors: Paolo Zanoni, Sumeet A. Khetarpal, Daniel B. Larach, William Hancock‐Cerutti, John S. Millar, Marina Cuchel, Stephanie DerOhannessian, Anatol Kontush, Praveen Surendran, Danish Saleheen, Stella Trompet, J. Wouter Jukema, Anton de Craen, Panos Deloukas, Naveed Sattar, Ian Ford, Chris J. Packard, Abdullah Al Shafi Majumder, Dewan S Alam, Emanuele Di Angelantonio, Gonçalo R. Abecasis, Rajiv Chowdhury, Jeanette Erdmann, Børge G. Nordestgaard, Sune F. Nielsen, Anne Tybjærg‐Hansen, Ruth Frikke‐Schmidt, Kari Kuulasmaa, Dajiang J. Liu, Markus Perola, Stefan Blankenberg, Veikko Salomaa, Satu Männistö, Philippe Amouyel, Dominique Arveiler, Jean Ferrières, Martina Müller‐Nurasyid, Maurizio Ferrario, Frank Kee, Cristen J. Willer, Nilesh J. Samani, Heribert Schunkert, Adam S. Butterworth, Joanna M. M. Howson, Gina M. Peloso, Nathan O. Stitziel, John Danesh, Sekar Kathiresan, Daniel J. Rader, Sarah Watson, Ellen M. Schmidt, Sebanti Sengupta, Stefan Gustafsson, Stavroula Kanoni, Andrea Ganna, Jin Chen, Martin L. Buchkovich, Samia Mora, J. Beckmann, Jennifer L. Bragg‐Gresham, Hsing‐Yi Chang, Ayşe Demirkan, Heleen M. den Hertog, Ron Do, Louise A. Donnelly, Georg Ehret, Tõnu Esko, Mary F. Feitosa, Teresa Ferreira, Krista Fischer, Pierre Fontanillas, Ross M. Fraser, Daniel F. Freitag, Deepti Gurdasani, Kauko Heikkilä, Elina Hyppönen, Aaron Isaacs, Anne Jackson, Åsa Johansson, Toby Johnson, Marika Kaakinen, Johannes Kettunen, Marcus E. Kleber, Xiaohui Li, Jian’an Luan, Leo‐Pekka Lyytikäinen, Patrik K. E. Magnusson, Massimo Mangino, Evelin Mihailov, May E. Montasser, Ilja M. Nolte, Jeffrey R. O’Connell, Cameron D. Palmer, Ann-Kristin Petersen, Serena Sanna, Richa Saxena, Susan K. Service, Sonia Shah, Dmitry Shungin, Carlo Sidore and 211 more - Science 2016 cited by 551

  14. Overproduction of large VLDL particles is driven by increased liver fat content in man

    Authors: Martin Adiels, Marja‐Riitta Taskinen, Chris J. Packard, Muriel Caslake, Aino Soro‐Paavonen, Jukka Westerbacka, Satu Vehkavaara, A. Häkkinen, S.‐O. Olofsson, Hannele Yki‐Järvinen, Jan Borén - Diabetologia 2006 cited by 692

  15. The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans

    Authors: Jan Borén, Chris J. Packard, Marja‐Riitta Taskinen - Frontiers in Endocrinology 2020 cited by 177

  16. Dietary Fructose and the Metabolic Syndrome

    Authors: Marja‐Riitta Taskinen, Chris J. Packard, Jan Borén - Nutrients 2019 cited by 298

  17. Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular Disease

    Authors: Brian A. Ference, Deepak L. Bhatt, Alberico L. Catapano, Chris J. Packard, Ian Graham, Stephen Kaptoge, Thatcher B. Ference, Qi Guo, Ulrich Laufs, Christian T. Ruff, Arjen J. Cupido, G. Kees Hovingh, John Danesh, Michael V. Holmes, George Davey Smith, Kausik K. Ray, Stephen J. Nicholls, Marc S. Sabatine - JAMA 2019 cited by 222

  18. Causes and Consequences of Hypertriglyceridemia

    Authors: Chris J. Packard, Jan Borén, Marja‐Riitta Taskinen - Frontiers in Endocrinology 2020 cited by 235

  19. Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance

    Authors: Chris J. Packard, Angela Pirillo, Sotirios Tsimikas, Brian A. Ference, Alberico L. Catapano - Cardiovascular Research 2023 cited by 50

  20. Lipid-Related Markers and Cardiovascular Disease Prediction

    Authors: Emanuele Di Angelantonio, Pei Gao, Lisa Pennells, Stephen Kaptoge, Muriel Caslake, Alexander Thompson, Adam S. Butterworth, Nadeem Sarwar, David Wormser, Danish Saleheen, Christie M. Ballantyne, Bruce M. Psaty, Johan Sundström, Paul M. Ridker, Dorothea Nagel, Richard F. Gillum, Ian Ford, Pierre Ducimetière, Stefan Kiechl, Robin P. F. Dullaart, Gerd Assmann, Ralph B. D’Agostino, Gilles R. Dagenais, Jackie A. Cooper, Daan Kromhout, Altan Onat, Robert Tipping, Agustı́n Gómez de la Cámara, Annika Rosengren, Susan E. Sutherland, John Gallacher, F. Gerry R. Fowkes, Edoardo Casiglia, Albert Hofman, Veikko Salomaa, Elizabeth Barrett‐Connor, Robert Clarke, Eric J. Brunner, J. Wouter Jukema, Leon A. Simons, Manjinder S. Sandhu, Nicholas J. Wareham, Kay‐Tee Khaw, Jussi Kauhanen, Jukka T. Salonen, W.J. Howard, Børge G. Nordestgaard, Angela Wood, Simon G. Thompson, S. Matthijs Boekholdt, Naveed Sattar, Chris J. Packard, Vilmundur Guðnason, John Danesh - JAMA 2012 cited by 536

  21. Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans

    Authors: Jan Borén, Martin Adiels, Elias Björnson, Niina Matikainen, Sanni Söderlund, Joel Rämö, Marcus Ståhlman, Pietari Ripatti, Samuli Ripatti, Aarno Palotie, Rosellina Margherita Mancina, Antti Hakkarainen, Stefano Romeo, Chris J. Packard, Marja‐Riitta Taskinen - JCI Insight 2020 cited by 71

  22. Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk

    Authors: Brian A. Ference, John J.P. Kastelein, Henry N. Ginsberg, M. John Chapman, Stephen J. Nicholls, Kausik K. Ray, Chris J. Packard, Ulrich Laufs, Robert D. Brook, Clare Oliver‐Williams, Adam S. Butterworth, John Danesh, George Davey Smith, Alberico L. Catapano, Marc S. Sabatine - JAMA 2017 cited by 328

  23. Pravastatin and cognitive function in the elderly. Results of the PROSPER study

    Authors: Stella Trompet, Peter Van de Vliet, Anton J.M. de Craen, Jelle Jolles, Brendan M. Buckley, Michael Murphy, Ian Ford, Peter W. Macfarlane, Naveed Sattar, Chris J. Packard, David J. Stott, Jim Shepherd, Eduard L. E. M. Bollen, Gerard J. Blauw, J. Wouter Jukema, Rudi G. J. Westendorp - Journal of Neurology 2009 cited by 287

  24. Targeting RNA With Antisense Oligonucleotides and Small Interfering RNA in Dyslipidemias

    Authors: Julius L. Katzmann, Chris J. Packard, M. John Chapman, Isabell Katzmann, Ulrich Laufs - Journal of the American College of Cardiology 2020 cited by 90